In accordance with CCRK up-regulation, phosphorylation of GSK3β, mTOR, and the downstream signaling molecules were concordantly increased in the liver tissues of both NASH and NASH-HCC models (Fig. 4c, d). Here, GSK3B is linked to metabolic dysfunction-associated steatohepatitis.